Cyclic peptide-based potent human SIRT6 inhibitors

来源 :中国生物化学与分子生物学会2016年全国学术会议 | 被引量 : 0次 | 上传用户:moreee
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  We discovered in the current study that six side chain-to-side chain cyclic pentapeptides harboring a central Nε-dodecyl(or tetradecyl)-thiocarbamoyl-lysine residue all behaved as highly potent(nM level)inhibitors against human SIRT6-catalyzed deacylation reaction.Moreover,one compound was also found to be selective for SIRT6 versus SIRT2/3/5(~20-,~11-,and >940-fold,respectively),despite its modest(~2.3-fold)SIRT6 inhibitory selectivity versus SIRT1.These compounds could be valuable leads for the identification of further potent and selective human SIRT6 inhibitors.
其他文献
Background:High iodine inhibits papillary thyroid carcinoma cell proliferation associated with TGFβ pathway activation,although thyroid cancers are frequently refractory to TGFβsignaling.The TGFβpathw
Imprinting of insulin-like growth factor-2 gene(IGF2)is maintained by binding of CCCTC binding factor(CTCF)to the unmethylated imprinting control region(ICR)between IGF2 and H19 genes.We previously sh
Pyruvate dehydrogenase(PDH)is a multi-enzyme complex in mitochondrion,which plays the crucial function in substance and energy metabolism.PDH catalyzes the decarboxylation of pyruvic acid to produce a
Spatial and temporal control of mRNA localization and translation plays critical roles in many events during germ cell development and asymmetric body pattern formation.Aberrant mRNA localization and
In the current study,we discovered that several N-terminus-to-side chain cyclic tripeptides harboring the catalytic mechanismbased SIRT1/2/3 inhibitory warhead Nε-thioacetyl-lysine at their central po
Laccases comprise a class of multi-copper containing oxidases that are environmentally friendly and industrially important.Laccases have low substrate specificity and can oxidize a wide range of subst
Ovarian cancer is the most lethal one of gynecologic malignancies.The clinical application of operation combined with radiotherapy,chemotherapy and other methods has improved the survival rate of pati
人血白蛋白(HSA),是人血浆中含量最丰富的一种蛋白质,能与许多内源性和外源性化合物结合,是一种重要的存储和转运蛋白.HSA 主要有两个药物结合位点,位点I 和位点Ⅱ,许多小分子优先结合在位点Ⅱ上,例如抗炎类药物布洛芬(α-甲基-4-(2-甲基丙基)苯乙酸).本文采用分子模拟方法研究布洛芬小分子与HSA 位点Ⅱ 结合的动态过程,探讨二者的结合机制.首先构建了50 个随机分布的布洛芬与HSA 复合物
混合模式层析(Mixed-mode Chromatography,MMC)是一种新型的生物分离技术,配基兼有两种或两种以上的功能基团,可以与目标物产生多种相互作用,提高结合的选择性.配基密度较高,吸附容量大,且具有非盐依赖特性,已在抗体分离纯化中得到应用,但对不同抗体类型的分离选择性尚待深入研究.本文选择典型混合模式介质MEP HyperCel,以及三种实验室自主设计的新型介质,以人IgG、IgA
G蛋白偶联受体(GPCR)是临床处方药物最重要的靶点,超过30%的临床处方药是直接作用在GPCR上的,相关的研究已经获得了10次诺贝尔奖.GPCR主要通过G蛋白或者Arrestin信号转导行使功能,然而无论是G蛋白还是Arrestin,如何识别特异的受体产生的信号指令,并翻译成下游的功能的机制是不清楚的.我们课题组应用最新的非天然氨基酸编码方法和19FNMR技术,发现Arrestin是通过识别受体